132 results on '"Rouesse, J."'
Search Results
2. Rapport 21-02. Le dépistage du cancer du poumon par scanner thoracique faible dose (STFD) reste non justifié, mais peut être utile pour un bilan de santé des fumeurs
Catalog
Books, media, physical & digital resources
3. Rapport 19-07. Rapport sur l’évolution des programmes de dépistage « organisé » des cancers du sein, du côlon et du rectum, et du col utérin, en France
4. Rapport 19-03. Analyse du plan « Ma Santé 2022, un engagement collectif » et propositions de l’Académie nationale de médecine
5. Prévention de la dépendance liée au vieillissement
6. La prévention en santé chez les adolescents
7. Diffusion et validation des tests génétiques en France
8. Recommandations de l’Académie nationale de médecine concernant le traitement des tumeurs malignes des tissus mous
9. Flow cytometric DNA analysis and Samba computer assisted image analysis in the evaluation of breast carcinoma chemosensitivity
10. Le corps médical à l’horizon 2015
11. Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution
12. Second and third line hormonotherapy in advanced post-menopausal breast cancer: a multicenter randomized trial comparing medroxyprogesterone acetate with aminoglutethimide in patients who have become resistant to tamoxifen
13. Survival effect of systemic therapy on patients developing metastatic breast carcinoma
14. Sur l’encadrement législatif des recherches biomédicales chez l’homme, à l’occasion de la transposition dans le droit français de la directive européenne
15. Sequential identification of factors predicting distant relapse in breast cancer patients treated by conservative surgery
16. Chemotherapy in Advanced Soft Tissue Sarcoma — The EORTC Experience
17. European Experience of Adjuvant Chemotherapy for Soft Tissue Sarcoma: Interim Report of a Randomized Trial of Cyvadic Versus Control
18. Antitumor Activity, Pharmacology, and Toxicity of Ellipticines, Ellipticinium, and 9-Hydroxy Derivatives: Preliminary Clinical Trials of 2-Methyl-9-Hydroxy Ellipticinium (NSC 264-137)
19. Granulocyte-macrophage colony-stimulating factor allows safe escalation of dose-intensity of chemotherapy in metastatic adult soft tissue sarcomas: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
20. J.BattinHistoires de médecine d’hier et d’aujourd’hui2020Editions GlypheParis
21. ADJUVANT CYVADIC CHEMOTHERAPY FOR ADULT SOFT-TISSUE SARCOMA-REDUCED LOCAL RECURRENCE BUT NO IMPROVEMENT IN SURVIVAL - A STUDY OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER SOFT-TISSUE AND BONE SARCOMA GROUP
22. Dose intensive therapy in breast-cancer
23. Le traitement du cancer du sein après 70 ans. A propos de 1143 cas
24. A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.
25. Predicting distant metastases in operable breast cancer patients
26. Doxorubicin in relapsed soft tissue sarcoma: Justification of phase II evaluation of new drugs in this disease
27. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system.
28. Reproducibility of a histopathologic grading system for adult soft tissue sarcoma.
29. Concurrent chemo-radiotherapy in operable breast cancer.
30. Le traitement du cancer du sein après 70 ans. A propos de 1143 cas
31. Phase II study of elliptinium acetate salvage treatment of advanced breast cancer
32. Phase II trial with high-dose elliptinium acetate in metastatic renal cell carcinoma
33. VP l6 in advanced soft tissue sarcomas: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group
34. Sites of primary malignancies in patients presenting with cerebral metastases. A review of 120 cases.
35. Twelve-Year Experience With Chemotherapy in Adult Metastatic Renal Cell Carcinoma at the Institut Gus-tave-Roussy
36. Review of the clinical trials activity of the soft tissue and bone sarcoma group of the european organization for research and treatment of cancer
37. CIS Platine (CDDP) in Continuous Intravenous Ambulatory Infusion: A New Method of Administration
38. The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy.
39. Interim Report of Phase II Study of New Nitrosourea S 10036 in Disseminated Malignant Melanoma
40. VP-16 in advanced soft tissue sarcoma: A phase II study of the EORTC soft tissue and bone sarcoma group
41. A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma
42. Drug-induced antibodies during 2-N-methyl-9-hydroxyellipticinium acetate (NSC-264137) treatment: schedule dependency and relationship to hemolysis.
43. Aminoglutethimide in advanced breast cancer: Clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/day
44. Phase II study of mitozolomide in advanced soft tissue sarcoma of adults: the EORTC Soft Tissue and Bone Sarcoma Group
45. The place of chemotherapy in the management of soft tissue sarcoma: Experiences of the EORTC soft tissue and bone sarcoma group
46. Chemotherapy in the multidisciplinary approach to soft tissue sarcomas: EORTC Soft Tissue and Bone Sarcoma Group studies in perspective
47. Phase II study of elliptinium in metastatic soft tissue sarcoma
48. 666 Have histological grade nuclear components (MSBR) of scarff bloom richardson (SBR) a prognostic value for lobular invasive breast carcinoma?
49. 871 Low efficacy of 1 hour infusion-high dose ifosfamide (IFO) in previously pretreated sarcoma
50. Sequential or simultaneous chemo-radiotherapy in operable breast cancer. A French multicentric phase III study — State of inclusions
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.